FORCE™ Platform Enables TFR1-Mediated Delivery of Therapeutics for Serious Muscle Diseases
Time: 4:30 pm
day: Day One
Details:
- Discovering key elements of the platform and considerations for oligonucleotide conjugate selection
- Understanding the FORCE translation into the clinic and the ACHIEVE & DELIVER trial data in DM1 and DMD
- Reviewing the FORCE efficacy in preclinical models of FSHD
